The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – JPMorgan upgraded IBM (IBM) to Overweight from Neutral with a price target of $291, up from $270. The firm cites its greater confidence in a second half of 2026 software acceleration following an analysis of IBM’s software business for the upgrade. – Wolfe Research upgraded Target (TGT) to Outperform from Peer Perform with a $162 price target. The analyst also named the stock a top pick into year-end.
Target is seeing improved execution as the new management team shakes up the status quo, the analyst tells investors in a research note. – Piper Sandler upgraded Synopsys (SNPS) to Overweight from Neutral with a price target of $550, up from $450. The firm sees a faster than-expected recovery for the company’s intellectual property business. – Morgan Stanley upgraded Qiagen (QGEN) to Overweight from Equal Weight with a price target of $42, up from $40. The firm says signs of a growth inflection coupled with sector underperformance in 2026 provides opportunities in the European medical technology space. – Morgan Stanley upgraded CDW (CDW) to Overweight from Equal Weight with a price target of $170, up from $142.